Concepedia

Pierre Sierocki

PS

2

Publications

37

Citations

2

H-Index

2022

Active since

Affiliations

Janssen (United States)(Current)

Pierre Sierocki is an author at Janssen (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2022–2022

2

Publications

2

Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target‐Guided Synthesis

Virgyl Camberlein, Charlotte Fléau, Pierre Sierocki et al. · Angewandte Chemie International Edition · 2022 · 21 citations · Full text

, , +15

Synthesis of novel <i>C</i>-nucleoside analogues bearing an anomeric cyano and a 1,2,3-triazole nucleobase as potential antiviral agents

Pierre Sierocki, Krystal Gaillard, Ruben Arturo Arellano Reyes et al. · Organic & Biomolecular Chemistry · 2022 · 16 citations

Rows per page

1–2 of 2